HRP980104A2 - Quinoxalinediones - Google Patents
QuinoxalinedionesInfo
- Publication number
- HRP980104A2 HRP980104A2 HR9715783.8A HRP980104A HRP980104A2 HR P980104 A2 HRP980104 A2 HR P980104A2 HR P980104 A HRP980104 A HR P980104A HR P980104 A2 HRP980104 A2 HR P980104A2
- Authority
- HR
- Croatia
- Prior art keywords
- formula
- compound
- pharmaceutically acceptable
- acceptable salt
- solvate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Addiction (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Luminescent Compositions (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP1997/000995 WO1997032873A1 (en) | 1996-03-09 | 1997-02-27 | Quinoxalinediones |
| GBGB9715783.8A GB9715783D0 (en) | 1997-02-27 | 1997-07-25 | Quinoxalinediones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP980104A2 true HRP980104A2 (en) | 1999-02-28 |
Family
ID=26070194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR9715783.8A HRP980104A2 (en) | 1997-02-27 | 1998-02-26 | Quinoxalinediones |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0973766B1 (hu) |
| JP (2) | JP3588363B2 (hu) |
| CN (2) | CN1121403C (hu) |
| AT (1) | ATE282608T1 (hu) |
| BG (1) | BG103685A (hu) |
| BR (1) | BR9808126A (hu) |
| CA (1) | CA2281580C (hu) |
| DE (1) | DE69827614T2 (hu) |
| ES (1) | ES2230685T3 (hu) |
| HR (1) | HRP980104A2 (hu) |
| HU (1) | HUP0003612A3 (hu) |
| NO (1) | NO994135L (hu) |
| NZ (1) | NZ336842A (hu) |
| SK (1) | SK113399A3 (hu) |
| TR (1) | TR199902055T2 (hu) |
| WO (1) | WO1998038186A1 (hu) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9605027D0 (en) * | 1996-03-09 | 1996-05-08 | Pfizer Ltd | Quinoxalinediones |
| GB0310881D0 (en) * | 2003-05-12 | 2003-06-18 | Merck Sharp & Dohme | Pharmaceutical formulation |
| MY145368A (en) * | 2004-01-13 | 2012-01-31 | Nissan Chemical Ind Ltd | Aminoquinoxaline compounds and polyaminoquinoxaline compounds, and use thereof |
| KR101170995B1 (ko) | 2004-02-06 | 2012-08-08 | 닛산 가가쿠 고교 가부시키 가이샤 | 에너지 저장 디바이스용 전극 및 그 제조 방법 |
| JP2009539846A (ja) * | 2006-06-06 | 2009-11-19 | ブリストル−ミエルス スクイッブ カンパニー | Ｎ−［５−［［［５−（１，１−ジメチルエチル）−２−オキサゾリル］メチル］チオ］−２−チアゾリル］−４−ピペリジンカルボキサミドの結晶形 |
| CN104370834B (zh) | 2007-05-17 | 2017-04-19 | 株式会社半导体能源研究所 | 三唑衍生物 |
| CN102812014B (zh) * | 2009-10-30 | 2016-01-20 | 多美恩医疗公司 | 新颖的肟衍生物及其作为代谢型谷氨酸受体的别构调节剂的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0556393B1 (en) * | 1990-11-06 | 2000-07-26 | Yamanouchi Pharmaceutical Co. Ltd. | Fused pyrazine derivative |
| DE4217952A1 (de) * | 1992-05-30 | 1993-12-02 | Basf Ag | Chinoxalin-2,3(1H,4H)-dione |
| GB9605027D0 (en) * | 1996-03-09 | 1996-05-08 | Pfizer Ltd | Quinoxalinediones |
-
1998
- 1998-02-24 EP EP98913660A patent/EP0973766B1/en not_active Expired - Lifetime
- 1998-02-24 ES ES98913660T patent/ES2230685T3/es not_active Expired - Lifetime
- 1998-02-24 CN CN98802879A patent/CN1121403C/zh not_active Expired - Fee Related
- 1998-02-24 NZ NZ336842A patent/NZ336842A/xx unknown
- 1998-02-24 JP JP53732798A patent/JP3588363B2/ja not_active Expired - Fee Related
- 1998-02-24 TR TR1999/02055T patent/TR199902055T2/xx unknown
- 1998-02-24 SK SK1133-99A patent/SK113399A3/sk unknown
- 1998-02-24 WO PCT/EP1998/001275 patent/WO1998038186A1/en active IP Right Grant
- 1998-02-24 CA CA002281580A patent/CA2281580C/en not_active Expired - Fee Related
- 1998-02-24 HU HU0003612A patent/HUP0003612A3/hu unknown
- 1998-02-24 BR BR9808126-8A patent/BR9808126A/pt not_active Application Discontinuation
- 1998-02-24 DE DE69827614T patent/DE69827614T2/de not_active Expired - Fee Related
- 1998-02-24 AT AT98913660T patent/ATE282608T1/de not_active IP Right Cessation
- 1998-02-26 HR HR9715783.8A patent/HRP980104A2/hr not_active Application Discontinuation
-
1999
- 1999-08-24 BG BG103685A patent/BG103685A/bg unknown
- 1999-08-26 NO NO994135A patent/NO994135L/no unknown
-
2003
- 2003-03-20 CN CN03107362A patent/CN1443763A/zh active Pending
-
2004
- 2004-07-02 JP JP2004196277A patent/JP2004269547A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1121403C (zh) | 2003-09-17 |
| CN1443763A (zh) | 2003-09-24 |
| EP0973766A1 (en) | 2000-01-26 |
| ATE282608T1 (de) | 2004-12-15 |
| DE69827614T2 (de) | 2005-11-10 |
| CA2281580C (en) | 2003-04-22 |
| JP3588363B2 (ja) | 2004-11-10 |
| NO994135L (no) | 1999-10-22 |
| BR9808126A (pt) | 2000-03-08 |
| CN1248971A (zh) | 2000-03-29 |
| JP2004269547A (ja) | 2004-09-30 |
| NZ336842A (en) | 2000-05-26 |
| BG103685A (bg) | 2000-06-30 |
| DE69827614D1 (de) | 2004-12-23 |
| TR199902055T2 (xx) | 2000-07-21 |
| WO1998038186A1 (en) | 1998-09-03 |
| ES2230685T3 (es) | 2005-05-01 |
| EP0973766B1 (en) | 2004-11-17 |
| NO994135D0 (no) | 1999-08-26 |
| JP2000509730A (ja) | 2000-08-02 |
| SK113399A3 (en) | 2001-04-09 |
| CA2281580A1 (en) | 1998-09-03 |
| HUP0003612A2 (hu) | 2001-10-28 |
| HUP0003612A3 (en) | 2003-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022071072A (ja) | （ｓ）－７－（１－アクリロイルピペリジン－４－イル）－２－（４－フェノキシフェニル）－４，５，６，７－テトラ－ヒドロピラゾロ［１，５－ａ］ピリミジン－３－カルボキサミドの結晶形、その調製、及びその使用 | |
| DE69331329T2 (de) | Heterocyclische ether-derivate zur verstärkung der cognitiven funktionen | |
| JP3534765B2 (ja) | 喘息治療用のニューロキニン２受容体拮抗薬としての新規な４−ピペリジニル置換ラクタム | |
| SK822002A3 (en) | New compounds | |
| EP3466962A1 (en) | Phenyl propanamide derivative, and manufacturing method and pharmaceutical application thereof | |
| JP2021518388A (ja) | オキサジアゾール一過性受容器電位チャネル阻害剤 | |
| HRP980104A2 (en) | Quinoxalinediones | |
| US5834482A (en) | Heterocyclic chemistry | |
| EP3541786B1 (en) | Tricyclic sulfones as ror gamma modulators | |
| CN113754635A (zh) | 稠环类化合物及其制备方法和用途 | |
| EP2513085B1 (en) | Bicyclic compounds as alpha4beta2 nicotinic acetylcholine receptor ligands | |
| AP982A (en) | Quinoxalinediones. | |
| JP2021512942A (ja) | トリアゾール、イミダゾールおよびピロール縮合ピペラジン誘導体、およびｍＧｌｕ５受容体のモジュレータとしてのそれらの使用 | |
| MXPA99007937A (en) | Quinoxalinediones | |
| CZ9903052A3 (cs) | Chinoxalindiony, způsoby a meziprodukty pro jejich výrobu, jejich použití, farmaceutické přípravky na jejich bázi a způsoby léčení | |
| WO2022123319A1 (en) | Biased agonists of opioid receptors | |
| CN117881664A (zh) | 作为nav1.8抑制剂的环烷基3-氧代哌嗪甲酰胺和环杂烷基3-氧代哌嗪甲酰胺 | |
| WO2022171265A1 (en) | Modulators of complex i | |
| JP2024546154A (ja) | 大環状ピリミジン誘導体、その製造方法、及び、それを活性成分として含む神経変性疾患の予防又は治療のための医薬組成物 | |
| AU2009355487C1 (en) | Bicyclic compounds as alpha4beta2 nicotinic acetylcholine receptor ligands | |
| NZ620653B2 (en) | Oxy-cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists | |
| MXPA06008934A (en) | Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
| A1OB | Publication of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20030130 Year of fee payment: 6 |
|
| ODBC | Application rejected |